Thermafiber Launches New and Improved Metal Mesh Blankets

New manufacturing technology improves industrial insulation product.

2010-10-01

WABASH, IN, October 01, 2010 (Press-News.org) Thermafiber, Inc. has re-launched its Metal Mesh Blanket product line with improved quality and additional product options. Investment in new manufacturing equipment for the metal mesh application contributed to the product advancements.

Metal Mesh Blankets are now available in multiple densities and offer various facing configurations. Metal Mesh Blankets offer the integrity and flexibility needed to insulate curved surfaces or irregular shapes. These products are ideal for boilers, tanks, ducts, large pipes and other high temperature applications.

"We are excited about the new capabilities that we have with the Metal Mesh product line. The new equipment with allow us to make a more cost effective and superior product for our customers," says Michael Williams, Thermafiber's Executive Vice President. "Metal Mesh Blankets continue to have strong demand internationally and more specifically this investment will allow us to better service the Latin American markets."

Like all Thermafiber mineral wool products, Metal Mesh Blankets have a high recycled content with a minimum 70% and available with up to 90%. All Thermafiber industrial insulation products conserve energy, control noise, and provide exceptional thermal performance in applications up to 1200 degrees F (649 degrees C).

Thermafiber, Inc., is a leading manufacturer of premium mineral wool insulation products for commercial, residential, industrial and marine applications. Thermafiber commercial insulation products are specified 4-to-1 over other brands and have been installed in 6 of the 8 tallest buildings in the world. To learn more about Thermafiber, visit www.thermafiber.com.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

Proofreading and Press Release Writing Company, Prompt Proofing, Launches Website

2010-10-01

Online proofreading and press release writing services company, Prompt Proofing, launched its new website today, Friday, October 1st, 2010. Prompt Proofing is run by a team of writing and editing professionals, which has experience in the education, news media, public relations and recruitment industries. This combined experience means that the team at Prompt Proofing is well prepared to assist clients with writing SEO-enhanced press releases, proofreading and editing a variety of documents and reviewing job application cover letters and resumes. All transactions ...

World's Largest Wholesale Magic Company Asks the World, "What Does Magic Mean to You?" - Your Response Could Win You a Free Magical Weekend for Two in Las Vegas to See Criss Angel Perform Live!

2010-10-01

Murphy's Magic Supplies, Inc. (MMS) is proud to announce the official launch of an exciting new contest, What Magic Means to You on MurphysMagicCommunity.com. The Grand Prize winner will receive a free trip for two to Las Vegas, NV and tickets to see the world-famous magician Criss Angel perform live. "The contest is simple," commented MMS General Manager, David Bickel. "Just describe what Magic Means to You by submitting a video blog, picture, blog entry, forum post or even a song, and upload it to MurphysMagicCommunity.com. Once it has been uploaded you have to share ...

Sadler's Smokehouse Features its Signature Brisket at the 31st American Royal Barbecue

2010-10-01

Sadler's Smokehouse, Ltd., North America's leader in premium, pit-smoked meats, will offer barbecue enthusiasts free samples of its famous pit-smoked brisket at the 31st annual American Royal Barbecue on October 1 - 3. The American Royal Barbecue is the opening event of the American Royal and the largest barbecue competition in the world. Located on more than 20 acres in Kansas City's historic Stockyards District, nearly 500 teams compete in four individual barbecue contests. Sadler's Smokehouse Brisket recently earned the Kansas City Barbeque Society seal of approval, ...

2010 AAO-HNSF miniseminars: Wednesday, Sept. 29, 2010

2010-09-30

Boston, MA – The 2010 Annual Meeting & OTO EXPO of the American Academy of Otolaryngology – Head and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ear, nose, and throat doctors in the world, will convene September 26-29, 2010, in Boston, MA. Featuring more than 305 scientific research sessions, 594 posters, and several hundred instruction course hours for attendees, the annual meeting is a unique opportunity for journalists from around the world to cover breaking science and medical news. Reporters will have access to the latest research and clinical advances ...

2010 AAO-HNSF new research daily highlights: Wednesday, Sept. 29, 2010

2010-09-30

Effect of Waiting Room Time on Ambulatory Satisfaction Presenters: Clifford Bleustein, MD, MBA; Eduardas Valaitis, PhD; Raleigh Jones, MD, MBA Time: 9:38 am Location: Room 259AB Boston, MA – Self-reported patient wait times alone significantly impacts all measured aspects of the ambulatory patient experience, as seen in survey responses. In a presentation at the 2010 AAO-HNSF Annual Meeting & OTO EXPO in Boston, researchers conducted a survey between January 1 and December 31, 2008 for the University of Kentucky Health System. Data collected across 12 questions were ...

Novel test following prostate surgery could detect cancer recurrence earlier

2010-09-30

DENVER — A new test could reliably detect early increases in prostate specific antigen (PSA) levels — a biomarker commonly used to measure the recurrence of prostate cancer — in men who have undergone prostate cancer-treating surgery. Earlier detection of these rising levels would allow men with cancer recurrence to undergo earlier, more effective treatment for potentially better outcomes. Data measuring the efficacy of this new test were presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development. "AccuPSA is a ...

MicroRNA panel provides a more precise lung cancer diagnosis

2010-09-30

DENVER — A test based on a panel of microRNAs under development by Rosetta Genomics, Ltd., in Rehovot, Israel, may allow for more precise diagnosis and better targeted therapy for patients with lung cancer. Tina B. Edmonston, M.D., director of the clinical laboratory at Rosetta Genomics, Inc., presented data on the assay at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development, held here. Lung cancers are traditionally divided into two main groups, either neuroendocrine or non-small cell lung cancer. In 20 to 30 percent ...

Screening tool can detect colorectal cancer from a small blood sample

2010-09-30

DENVER — A new microRNA (miRNA) screening assay detected the majority of early-stage colorectal cancers with good specificity and sensitivity. "Our test has the potential to be safe, cheap, robust, accurate and of little or no inconvenience to the individual, and could, therefore, easily be integrated into national screening programs as part of an annual checkup," said Søren Jensby Nielsen, Ph.D., scientific manager, Diagnostic Product Development, Exiqon A/S. Nielsen presented the results at the Fourth AACR International Conference on Molecular Diagnostics in Cancer ...

Dual-capture CTC chip efficiently captures breast cancer cells

2010-09-30

DENVER — Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer. Analyzing CTCs in blood can identify cancer cells and cancer cell mutations to provide physicians with methods for improved cancer diagnosis, prognosis and treatment. In order to efficiently capture CTCs, two capture mechanisms were used to trap CTCs by antibody affinity and size. ...

IV treatment may lower risk of dying from bacterial meningitis

2010-09-30

ST. PAUL, Minn. – New research shows that an intravenous (IV) treatment may cut a person's risk of dying from bacterial meningitis. The research is published in the September 29, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. The treatment is called dexamethasone. "Using this treatment in people infected with meningitis has been under debate because in a few large studies it was shown to be ineffective," said study author Diederik van de Beek, MD, PhD, with the Academic Medical Center, University of Amsterdam in the Netherlands ...

Thermafiber Launches New and Improved Metal Mesh Blankets

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: